Your browser doesn't support javascript.
loading
Body mass index and weight change are associated with adult lung function trajectories: the prospective ECRHS study.
Peralta, Gabriela P; Marcon, Alessandro; Carsin, Anne-Elie; Abramson, Michael J; Accordini, Simone; Amaral, André Fs; Antó, Josep M; Bowatte, Gayan; Burney, Peter; Corsico, Angelo; Demoly, Pascal; Dharmage, Shyamali; Forsberg, Bertil; Fuertes, Elaine; Garcia-Larsen, Vanessa; Gíslason, Thorarinn; Gullón, José-Antonio; Heinrich, Joachim; Holm, Mathias; Jarvis, Deborah L; Janson, Christer; Jogi, Rain; Johannessen, Ane; Leynaert, Bénédicte; Rovira, Jesús Martínez-Moratalla; Nowak, Dennis; Probst-Hensch, Nicole; Raherison, Chantal; Sánchez-Ramos, José-Luis; Sigsgaard, Torben; Siroux, Valérie; Squillacioti, Giulia; Urrutia, Isabel; Weyler, Joost; Zock, Jan-Paul; Garcia-Aymerich, Judith.
Afiliação
  • Peralta GP; ISGlobal, Barcelona, Spain.
  • Marcon A; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Carsin AE; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Abramson MJ; Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Accordini S; ISGlobal, Barcelona, Spain.
  • Amaral AF; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Antó JM; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Bowatte G; IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
  • Burney P; School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Corsico A; Unit of Epidemiology and Medical Statistics, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
  • Demoly P; National Heart and Lung Institute, Imperial College London, London, UK.
  • Dharmage S; ISGlobal, Barcelona, Spain.
  • Forsberg B; Universitat Pompeu Fabra (UPF), Barcelona, Spain.
  • Fuertes E; CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • Garcia-Larsen V; Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population & Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Gíslason T; National Institute of Fundamental Studies, Kandy, Sri Lanka.
  • Gullón JA; National Heart and Lung Institute, Imperial College London, London, UK.
  • Heinrich J; Division of Respiratory Diseases, IRCCS 'San Matteo' Hospital Foundation-University of Pavia, Pavia, Italy.
  • Holm M; Département de Pneumologie et Addictologie, Hôpital Arnaud de Villeneuve, University Hospital of Montpellier, Montpellier, France.
  • Jarvis DL; UMr-S 1136 inSerM, iPleSP, UPMc, Sorbonne Universités, Paris, France.
  • Janson C; Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population & Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Jogi R; Section of Sustainable Health, Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  • Johannessen A; National Heart and Lung Institute, Imperial College London, London, UK.
  • Leynaert B; Program in Human Nutrition, Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Rovira JM; Department of Sleep, Landspitali University Hospital Reykjavik, Reykjavik, Iceland.
  • Nowak D; Medical Faculty University of Iceland, Reykjavik, Iceland.
  • Probst-Hensch N; Department of Pneumology, Hospital San Agustin, Avilés, Spain.
  • Raherison C; Allergy and Lung Health Unit, Centre for Epidemiology and Biostatistics, School of Population & Global Health, The University of Melbourne, Melbourne, Victoria, Australia.
  • Sánchez-Ramos JL; Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital Munich (LMU), Munich, Germany.
  • Sigsgaard T; Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany.
  • Siroux V; Department of Occupational and Environmental Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.
  • Squillacioti G; National Heart and Lung Institute, Imperial College London, London, UK.
  • Urrutia I; MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.
  • Weyler J; Department of Medical Sciences, Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
  • Zock JP; Lung Clinic, Tartu University Hospital, Tartu, Estonia.
  • Garcia-Aymerich J; Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway.
Thorax ; 75(4): 313-320, 2020 04.
Article em En | MEDLINE | ID: mdl-32098862
BACKGROUND: Previous studies have reported an association between weight increase and excess lung function decline in young adults followed for short periods. We aimed to estimate lung function trajectories during adulthood from 20-year weight change profiles using data from the population-based European Community Respiratory Health Survey (ECRHS). METHODS: We included 3673 participants recruited at age 20-44 years with repeated measurements of weight and lung function (forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1)) in three study waves (1991-93, 1999-2003, 2010-14) until they were 39-67 years of age. We classified subjects into weight change profiles according to baseline body mass index (BMI) categories and weight change over 20 years. We estimated trajectories of lung function over time as a function of weight change profiles using population-averaged generalised estimating equations. RESULTS: In individuals with normal BMI, overweight and obesity at baseline, moderate (0.25-1 kg/year) and high weight gain (>1 kg/year) during follow-up were associated with accelerated FVC and FEV1 declines. Compared with participants with baseline normal BMI and stable weight (±0.25 kg/year), obese individuals with high weight gain during follow-up had -1011 mL (95% CI -1.259 to -763) lower estimated FVC at 65 years despite similar estimated FVC levels at 25 years. Obese individuals at baseline who lost weight (<-0.25 kg/year) exhibited an attenuation of FVC and FEV1 declines. We found no association between weight change profiles and FEV1/FVC decline. CONCLUSION: Moderate and high weight gain over 20 years was associated with accelerated lung function decline, while weight loss was related to its attenuation. Control of weight gain is important for maintaining good lung function in adult life.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Função Respiratória / Peso Corporal / Índice de Massa Corporal / Estilo de Vida / Obesidade Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Testes de Função Respiratória / Peso Corporal / Índice de Massa Corporal / Estilo de Vida / Obesidade Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Espanha